Hypoglycaemia was more common with background SU than background MET only, regardless of whether subjects received semaglutide or a comparator, and the frequency of adverse events leading to premature treatment discontinuations with semaglutide treatment was consistent regardless of background therapy
However, individual responses vary, and management strategies including adequate hydration and gradual dose escalation may help minimize this effect
In these situa-tions, care should not be delayed. Anesthesiologists Have the Final Say Following the AGA clinical update, Ali Rezaie, MD, director of the GI motility program at Cedars Sinai in Los Angeles, recalled there being tension among all those involved in managing preoperative care for GLP-1 users
This review was supported by grants from the Wu Jieping Medical Foundation Research Special Project (no
When a drug becomes both medically and culturally significant, costs tend to rise quickly